The largest database of trusted experimental protocols

Anti cd8 mabs

Manufactured by BD

Anti-CD8 monoclonal antibodies (mAbs) are laboratory reagents used to detect and quantify CD8-positive cells in various biological samples. They specifically bind to the CD8 surface marker expressed on a subset of T lymphocytes and other cell types. These mAbs can be used in flow cytometry, immunohistochemistry, and other immunoassay techniques to analyze the presence and distribution of CD8-positive cells.

Automatically generated - may contain errors

2 protocols using anti cd8 mabs

1

Cytotoxicity Assay of Tumor-Specific CTLs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytoxicity of CTLs of immunized mice was determined by quantitative measurements of the release of lactic dehydrogenase (LDH). The mouse melanoma B16 cells (H-2b), colon carcinoma CT26 cells (H-2d) or 2E8 cells (mBAP31-depleted B16 cells) were pulsed with or without corresponding peptides (2 μg/mL) and used as target cells. CD8+ cells, isolated from splenocytes of immunized C57BL/6 mice by magnetic beads conjugated with anti-CD8 mAbs (BD pharmingen), served as effector cells. CTL assays were performed with effector cells (E) and target cells (T) (1 × 104 cells/well) mixed together at ratios of 50:1, 25:1 or 12.5:1 in a final volume of 100 μl. After 4 h incubation at 37°C, 50 μl of the cultured supernatants was collected to assess the amount of LDH release using Non-Radioactive Cytotoxicity Assay kits (Promega). The percentage of target cell lysis was calculated from the following equation: 100 × (A-B)/(C-D), where A is the reading value of experimental signal, B is spontaneous background signal value of the effector cells, C is maximum signal value from target cells, and D is spontaneous background signal value of the target cells.
+ Open protocol
+ Expand
2

Chemotaxis of CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemotaxis of CD8 + T lymphocyte cells was analyzed in a transwell system (Corning, Tewksbury, MA, USA) using 5-μm polycarbonate membranes. 20 Prior to the assay, bladder cancer cells were added in lower chamber. After incubation at 37℃ for 24h, CD8 + T lymphocytes were added to the top wells and incubated 4 h. Following incubation, migrated CD8 + T cells were harvested from the lower chamber and stained with anti-CD8 mAbs (BD Biosciences). After staining, Precision Count Beads (Biolegend, USA) were added, and the numbers of migrated CD8 + T cells were determined using ow cytometry (BD Biosciences).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!